#  AIM in the News 

 



 ##  

  expand\_more  

 
  

 

Manrai Lab

#### Study Suggests AI Is Good Enough at Diagnosing Complex Medical Cases To Warrant Clinical Testing 

 

LLM outperformed physicians on clinical tasks spanning published cases, real-world emergency room data



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/study-suggests-ai-good-enough-diagnosing-complex-medical-cases-warrant-clinical-testing?utm_source=OCERMarketingCloud&utm_medium=email&utm_campaign=05.05.2026-HMNews&utm_content=Study+Suggests+AI+Is+Good+Enough+at+Diagnosing+Complex+Medical+Cases+To+Warrant+Clinical+Testing) 

 





 

 

 

Yu Lab

#### Researchers Discover Bias in AI Models That Analyze Pathology Samples 

 

The team created a new tool that reduces bias and improves cancer diagnosis across populations



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/researchers-discover-bias-ai-models-analyze-pathology-samples) 

 





 

 

 

Manrai Lab

#### An AI System With Detailed Diagnostic Reasoning Makes Its Case 

 

Researchers have developed an AI system called Dr. CaBot that spells out its reasoning as it works through challenging medical cases and reaches a diagnosis.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/ai-system-detailed-diagnostic-reasoning-makes-its-case) 

 





 

 

 

Yu Lab

#### AI Distinguishes Glioblastoma From Look-Alike Cancers During Surgery 

 

New tool helps surgeons tell apart aggressive glioblastoma from other cancers in the brain, guiding real-time treatment decisions.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/ai-distinguishes-glioblastoma-look-alike-cancers-during-surgery) 

 





 

 

 

Zitnik Lab

#### New AI Tool Pinpoints Genes, Drug Combos To Restore Health in Diseased Cells 

 

New AI tool accurately identifies multiple drivers of disease in cells and predicts therapies that can restore cells to healthy function.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/new-ai-tool-pinpoints-genes-drug-combos-restore-health-diseased-cells) 

 





 

 

 

Rajpurkar Lab

#### How Good Are AI ‘Clinicians’ at Medical Conversations? 

 

Researchers design a new way to more reliably evaluate AI models’ ability to make clinical decisions in realistic scenarios that closely mimic real-life interactions.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/how-good-are-ai-clinicians-medical-conversations) 

 





 

 

 

Zitnik Lab

#### Researchers Harness AI to Repurpose Existing Drugs for Treatment of Rare Diseases 

 

New AI model identifies possible therapies from existing medicines for thousands of diseases, including rare ones with no current treatments.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/researchers-harness-ai-repurpose-existing-drugs-treatment-rare-diseases) 

 





 

 

 

Yu Lab

#### A New Artificial Intelligence Tool for Cancer 

 

The new approach marks a major step forward in the design of AI tools to support clinical decisions in cancer diagnosis, therapy.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/new-artificial-intelligence-tool-cancer) 

 





 

 

 

Zitnik Lab

#### New AI Tool Captures How Proteins Behave in Context 

 

In a marked advance over current AI models, the new approach captures how proteins act not in isolation but in their cellular and tissue environments.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/new-ai-tool-captures-how-proteins-behave-context) 

 





 

 

 

Mahmood Lab

#### Researchers Design Foundation AI Models for Use in Pathology 

 

Flexible models show promise in diagnosis, prognosis, and prediction of treatment response in multiple clinical scenarios.



 [ Full story arrow\_circle\_right ](https://hms.harvard.edu/news/researchers-design-foundation-ai-models-use-pathology)